Gregory D. Gorgas's most recent trade in Artelo Biosciences Inc was a trade of 154,713 Stock Options (right to buy) done . Disclosure was reported to the exchange on Jan. 29, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Artelo Biosciences Inc | Gregory D. Gorgas | Director, Pres, CEO, CFO, Treas & Secr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2026 | 154,713 | 154,713 | - | - | Stock Options (right to buy) | |
| Artelo Biosciences Inc | Gregory D. Gorgas | Director, President, CEO, Treasurer, Sec | 28 Oct 2025 | 17,952 | 17,952 | - | - | Warrant (right to buy) | ||
| Artelo Biosciences Inc | Gregory D. Gorgas | Director, President, CEO, Treasurer, Sec | 28 Oct 2025 | 9,586 | 9,586 | - | - | Warrant (right to buy) | ||
| Artelo Biosciences Inc | Gregory D. Gorgas | Director, President, CEO, CFO, Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2025 | 20,393 | 20,393 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | Gregory D. Gorgas | Director, President, CEO, CFO, Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2025 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | Gregory D. Gorgas | Director, Pres, CEO, CFO, Treas & Sec | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Feb 2024 | 90,334 | 0 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | Gregory D. Gorgas | Director, Pres, CEO, CFO, Treas & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 90,334 | 90,334 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | Gregory D. Gorgas | Director, Pres, CEO, CFO, Treas & Sec | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Feb 2024 | 85,000 | 0 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | Gregory D. Gorgas | Director, Pres, CEO, CFO, Treas & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 85,000 | 85,000 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | Gregory D. Gorgas | Director, Pres, CEO, CFO, Treas & Sec | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Feb 2024 | 55,634 | 0 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | Gregory D. Gorgas | Director, Pres, CEO, CFO, Treas & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 55,634 | 55,634 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | Gregory D. Gorgas | Director, Pres, CEO, CFO, Treas & Sec | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Feb 2024 | 38,340 | 0 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | Gregory D. Gorgas | Director, Pres, CEO, CFO, Treas & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 38,340 | 38,340 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | Gregory D. Gorgas | Director, Pres, CEO, CFO, Treas & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | Gregory D. Gorgas | Director, Pres, CEO, CFO, Treas & Sec | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Feb 2024 | 5,000 | 0 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | D. Gorgas Gregory | Director, Pres, CEO, CFO, Treas & Secr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 92,000 | 92,000 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | Gregory D. Gorgas | Director, Pres, CEO, CFO, Treas & Secr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 85,000 | 85,000 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | Gregory D. Gorgas | Director, Pres, CEO, CFO, Treas & Secr | Purchase of securities on an exchange or from another person at price $ 4.03 per share. | 11 Aug 2022 | 1,200 | 1,200 (0%) | 0% | 4.0 | 4,836 | Common Stock |
| Artelo Biosciences Inc | Gregory D. Gorgas | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2021 | 1,355,000 | 1,355,000 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | Gregory D. Gorgas | Director, Pres, CEO, CFO, Treas & Secr | Purchase of securities on an exchange or from another person at price $ 1.15 per share. | 16 Apr 2021 | 8,500 | 270,676 (7%) | 0% | 1.2 | 9,809 | Common Stock |